Outlook Therapeutics plans to resubmit ONS-5010 for FDA approval in 2025 following NORSE EIGHT trial results in wet AMD ...

ITT holds the potential to reap benefits driven by strength across its segments. However, cost inflation remains concerning.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? ITT (ITT), which belongs to the Zacks ...

ITT (ITT) announced its Cannon connectors have been qualified for deployment on the Nett Warrior soldier-worn mission command system by the ...

Analysts have set 12-month price targets for ITT, revealing an average target of $173.17, a high estimate of $183.00, and a ...

Citi lowered the firm’s price target on ITT (ITT) to $181 from $183 and keeps a Buy rating on the shares. The Q4 earnings for industrial ...

ITT to Release 2024 Fourth Quarter and Full Year Results and 2025 Outlook on Thursday, Feb. 6 ...

Check the time stamp on this data. Updated AI-Generated Signals for Itt Inc. (ITT) available here: ITT. Type a few symbols ...

The Supreme Court decided Friday to take up the Biden administration’s appeal defending its proposal to ease applications for ...

AIG commercial lines programmes EVP and Glatfelter Insurance Group president Erin Fry will succeed Flatt as head of AIG North ...

Salt Lake City races rebranded Utah Crits, Tour of the Gila opens with ITT on April 23 - North American Roundup ...

ITT's performance remains robust despite recent market shifts.,Everence Capital Management Invests in ITT Inc.,... "Lorem ...